로딩 중…
지수 로딩 중…
Celltrion Pharm, Inc.
068760· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩41,900-3.23%
2026-06-19
Price Chart
Celltrion Pharm, Inc.-13.85%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 1.86T KRW |
| Revenue | 556.00B KRW |
| Net Income | 40.25B KRW |
| Total Assets | 768.81B KRW |
| Net Assets | 434.82B KRW |
| Employees | 920 |
| Value | |
| P/E | 46.22x |
| P/B | 4.28x |
| PEG | 2.26x |
| P/S | 3.35x |
| EV/EBITDA | 122.45x |
| FCF Yield | 3.78% |
| Profitability | |
| ROE | 9.26% |
| ROA | 5.24% |
| Op. Margin | 10.48% |
| Revenue Growth | 17.42% |
| Earnings Growth | 20.44% |
| Financial Health | |
| Debt Ratio | 176.81% |
| Total Debt | 142.00B KRW |
| FCF | 70.27B KRW |
| Cash | 56.79B KRW |
| Current Ratio | 1.65x |
| Net Debt/EBITDA | 5.36x |
| Dividend | |
| Div. Yield | 0.45% |
| Performance | |
| 1Y Return | -13.85% |
| 1M Return | -10.85% |
| From 52W High | -46.49% |
| 1Y MDD | -46.50% |
| Trading | |
| Volume | 129,958 shares |
| Foreign Own. | 5.27% |
| Per Share | |
| EPS | 903 KRW |
| BPS | 9,849 KRW |
Company Info
This specialized pharmaceutical manufacturing and sales company was established in 2000 and listed on KOSDAQ in 2006. It operates KGMP, US cGMP, and EU-GMP certified facilities in Ochang and Jincheon, Chungcheongbuk-do, producing specialized pharmaceuticals and biopharmaceuticals via PFS production lines. The company holds domestic exclusive sales rights for chemical pharmaceuticals like the liver disease treatment Godex, and 12 biopharmaceuticals, including autoimmune disease treatments and anti-cancer drugs developed by its parent company, Celltrion, while actively pursuing pipeline expansion and technological platform innovation.